Insulin lispro biosimilar - Sanofi
At a glance
- Drug Originator Sanofi
- Drug Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
- USA Patent Applicants SANOFI-AVENTIS US
- USA Patents 116
- BLAs 1
- International Patents 1,492

Disclaimer